These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 16928354)

  • 21. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
    Chalmers KA; Love S
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies.
    Villar-Piqué A; Lopes da Fonseca T; Outeiro TF
    J Neurochem; 2016 Oct; 139 Suppl 1():240-255. PubMed ID: 26190401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endosomal sorting related protein CHMP2B is localized in Lewy bodies and glial cytoplasmic inclusions in α-synucleinopathy.
    Tanikawa S; Mori F; Tanji K; Kakita A; Takahashi H; Wakabayashi K
    Neurosci Lett; 2012 Oct; 527(1):16-21. PubMed ID: 22947304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
    Goedert M
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The interaction of α-synuclein and Tau: A molecular conspiracy in neurodegeneration?
    Yan X; Uronen RL; Huttunen HJ
    Semin Cell Dev Biol; 2020 Mar; 99():55-64. PubMed ID: 29738880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein Partners of α-Synuclein in Health and Disease.
    Lassen LB; Reimer L; Ferreira N; Betzer C; Jensen PH
    Brain Pathol; 2016 May; 26(3):389-97. PubMed ID: 26940507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation.
    Uversky VN
    J Neurochem; 2007 Oct; 103(1):17-37. PubMed ID: 17623039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson's disease?
    Volpicelli-Daley LA; Kirik D; Stoyka LE; Standaert DG; Harms AS
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl 1):131-155. PubMed ID: 27018978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is malfunction of the ubiquitin proteasome system the primary cause of alpha-synucleinopathies and other chronic human neurodegenerative disease?
    Bedford L; Hay D; Paine S; Rezvani N; Mee M; Lowe J; Mayer RJ
    Biochim Biophys Acta; 2008 Dec; 1782(12):683-90. PubMed ID: 18976704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease.
    Castro-Sánchez S; García-Yagüe ÁJ; López-Royo T; Casarejos M; Lanciego JL; Lastres-Becker I
    Glia; 2018 Aug; 66(8):1752-1762. PubMed ID: 29624735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct region-specific alpha-synuclein oligomers in A53T transgenic mice: implications for neurodegeneration.
    Tsika E; Moysidou M; Guo J; Cushman M; Gannon P; Sandaltzopoulos R; Giasson BI; Krainc D; Ischiropoulos H; Mazzulli JR
    J Neurosci; 2010 Mar; 30(9):3409-18. PubMed ID: 20203200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prion-like Propagation of Pathological α-Synuclein in Vivo].
    Masuda-Suzukake M; Hasegawa M
    Yakugaku Zasshi; 2019; 139(7):1007-1013. PubMed ID: 31257247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting α-synuclein by PD03 AFFITOPE® and Anle138b rescues neurodegenerative pathology in a model of multiple system atrophy: clinical relevance.
    Lemos M; Venezia S; Refolo V; Heras-Garvin A; Schmidhuber S; Giese A; Leonov A; Ryazanov S; Griesinger C; Galabova G; Staffler G; Wenning GK; Stefanova N
    Transl Neurodegener; 2020 Sep; 9(1):38. PubMed ID: 32972456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. D409H GBA1 mutation accelerates the progression of pathology in A53T α-synuclein transgenic mouse model.
    Kim D; Hwang H; Choi S; Kwon SH; Lee S; Park JH; Kim S; Ko HS
    Acta Neuropathol Commun; 2018 Apr; 6(1):32. PubMed ID: 29703245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Propagation of pathological α-synuclein in marmoset brain.
    Shimozawa A; Ono M; Takahara D; Tarutani A; Imura S; Masuda-Suzukake M; Higuchi M; Yanai K; Hisanaga SI; Hasegawa M
    Acta Neuropathol Commun; 2017 Feb; 5(1):12. PubMed ID: 28148299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. α-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease.
    Sorrentino ZA; Giasson BI; Chakrabarty P
    Acta Neuropathol; 2019 Jul; 138(1):1-21. PubMed ID: 30798354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-synuclein propagation: New insights from animal models.
    Dehay B; Vila M; Bezard E; Brundin P; Kordower JH
    Mov Disord; 2016 Feb; 31(2):161-8. PubMed ID: 26347034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of GBA in zebrafish leads to dopaminergic neurodegeneration, but overexpression of α-synuclein does not further worsen degeneration.
    Kodera K; Matsui N; Saitoh A; Matsui H
    Neuroreport; 2022 May; 33(7):320-325. PubMed ID: 35594444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy.
    Spencer B; Valera E; Rockenstein E; Overk C; Mante M; Adame A; Zago W; Seubert P; Barbour R; Schenk D; Games D; Rissman RA; Masliah E
    Acta Neuropathol Commun; 2017 Jan; 5(1):7. PubMed ID: 28086964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.